These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. China tightens IP protection, but concerns linger. Jia H Nat Biotechnol; 2009 Sep; 27(9):787-8. PubMed ID: 19741619 [No Abstract] [Full Text] [Related]
4. Property rights go East. Nature; 2005 Nov; 438(7067):420-1. PubMed ID: 16306959 [No Abstract] [Full Text] [Related]
5. Drug development. A European-inspired renaissance for China's drug industry? Xin H Science; 2007 Jul; 317(5837):436-7. PubMed ID: 17656689 [No Abstract] [Full Text] [Related]
6. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
7. IP litigation in China could drive innovation. Jia H Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539 [No Abstract] [Full Text] [Related]
8. Intellectual property and its role in the pharmaceutical industry. Atkinson JD; Jones R Future Med Chem; 2009 Dec; 1(9):1547-50. PubMed ID: 21425976 [No Abstract] [Full Text] [Related]
9. Intellectual property. Fixing the legal framework for pharmaceutical research. Knowles SM Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445 [No Abstract] [Full Text] [Related]
10. Intellectual property protection for traditional medical knowledge in China's context: a round peg in a square hole? Xia N Med Law Rev; 2023 Aug; 31(3):358-390. PubMed ID: 37018625 [TBL] [Abstract][Full Text] [Related]
12. Position and enforcement practice of the People's Republic of China's pharmaceutical data exclusivity protection. Li N; Yu X; Pecht M Drug Des Devel Ther; 2016; 10():2015-20. PubMed ID: 27382254 [TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions and adverse events of 33 varieties of traditional Chinese medicine injections on National Essential medicines List (2004 edition) of China: an overview on published literatures. Wang L; Yuan Q; Marshall G; Cui X; Cheng L; Li Y; Shang H; Zhang B; Li Y J Evid Based Med; 2010 May; 3(2):95-104. PubMed ID: 21349051 [TBL] [Abstract][Full Text] [Related]
14. Intellectual property. U.S. Court opens door to free trade in ideas. Malakoff D Science; 2003 Sep; 301(5640):1643. PubMed ID: 14500946 [No Abstract] [Full Text] [Related]
15. From exotic spice to modern drug? Singh S Cell; 2007 Sep; 130(5):765-8. PubMed ID: 17803897 [TBL] [Abstract][Full Text] [Related]
16. Auctioning the cure. Willyard C Nat Med; 2011 May; 17(5):528-30. PubMed ID: 21546960 [No Abstract] [Full Text] [Related]
17. Intellectual property. U.S. patent reform begins long journey through Congress. Kintisch E Science; 2005 Jun; 308(5729):1725-6. PubMed ID: 15961638 [No Abstract] [Full Text] [Related]
18. Health-care patents and interests of patients. Luthra R Bull World Health Organ; 2006 Nov; 84(11):919. PubMed ID: 17143470 [No Abstract] [Full Text] [Related]
20. Analysis of anti-asthmatic drug patents published in China between 2004 and 2013. Xie H; Zhang H; Cao K; He P; Dai H; He S Expert Opin Ther Pat; 2016; 26(3):363-76. PubMed ID: 26742645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]